4th Quarter - Report

GENZYME CORPORATION for GENZYME CORPORATION

Firm
Client
Income
—
Expenses
$600,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for Medical Devices P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics P.L. 111-152, Health Care and Education Reconciliation Act of 2010

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of

Bills named: H.R. 3156 (111th)

Copyright/Patent/Trademark CPT

S. 515, Patent Reform Act of 2009 H.R. 1260, Patent Reform Act of 2009 S. 610, Patent Reform Act of 2009 S. 3677 Financial Services and General Appropriations Act 2011 (Patent Settlement Provisions)

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: S. 610 (111th), S. 515 (111th), H.R. 1260 (111th), S. 3677 (111th)

Medicare/Medicaid MMM

H.R. 444, 340B Program Improvement and Integrity Act of 2009, 340B drug price expansion ESRD "Bundling Issues" and ESRD Drug Reimbursement Issues HCPCS Coding Decisions Reimbursement for Part B Drugs Administered in Hospital Out-patient Departments, Dialysis Centers and Physician Offices Physician Fee Schedule Payment Rates for Lab Tests Medicaid Rebates Implementation of MIPPA H.R. 1699, Patient Access to Critical Lab Test H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 Reimbursement /Payment Laboratory Tests H.R. 676, US National Health Care Act or the Expanded and Improved Medicare for All Act Reimbursement for Clinical Lab Tests Reimbursement for Medicare Part D Drugs P.L. 111-148, Patient Protection & Affordable Health Care Act P.L. 111-152, Health Care and Education Reconciliation Act of 2010 S. 11, To Restore the Application of the 340B Drug Discount Program to Orphan Drugs with Respect to Children's Hospitals S. Amendment (Baucus) to H.R. 4848, Small Business and Infrastructure Jobs Tax Act of 2010 (340B Provisions) H.R. 1586, Education Jobs and Medicaid Funding Bill (AMP Revisions) H.R. 4899, Supplemental Appropriations Act 2010 (AMP Revisions) H.R.5712, Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Children's Hospitals Provision) Health Care Reform Implementation Issues

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

Bills named: H.R. 5712 (111th), H.R. 444 (111th), H.R. 1586 (111th), H.R. 4848 (111th), S. 11 (111th), H.R. 676 (111th), H.R. 1452 (111th), H.R. 4899 (111th), H.R. 1699 (111th)

Budget/Appropriations BUD

P.L. 111-152, Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: SENATE; Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3081 (111th), H.R. 3082 (111th), H.J.Res. 101 (111th), H.J.Res. 105 (111th), S. 3686 (111th)

Pharmacy PHA

H.R. 3156, Neglected Disease Tax Credit Bill H.R. 759, Food and Drug Administration Globalization Act of 2009 P.L. 111-148, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion P.L. 111-152, Health Care and Education Reconciliation Act of 2010 H.R. 3081, Continuing Appropriations Act of 2011 (340B Provisions) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: H.R. 759 (111th), H.R. 3156 (111th), S. 11 (111th), H.R. 3081 (111th)

Medical/Disease Research/Clinical Labs MED

H.R. 1452, Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 Reimbursement for Clinical Lab Services under Medicare Excise Tax for Laboratory Services P.L. 111-148, Patient Protection & Affordable Health Care Act

LobbyistCovered position, as disclosed
SARA FROELICH Vice President
KATHLEEN HOLCOMBE Senior Policy Advisor
MARY MCGRANE Senior Vice President

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of

Bills named: H.R. 1452 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.